Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.

In conclusion, in the real-life setting, discontinuation of inhaled long-acting bronchodilators in adults with COPD is high even after just 6 months, even though persistence to these drugs reduces the risk of severe outcomes. PMID: 26934569 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26934569?dopt=Abstract

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - March 6, 2016 Category: Respiratory Medicine Tags: COPD Source Type: research